With one eye on the future

In the past 20 years we have seen the rise of a new era of cancer research that moved its focus away from the cancer cell itself and revealed a complexity of interactions, both within the tumor and with the host, that ultimately dictate the evolution and progression of the disease. We have witnessed the development of immunotherapies that changed the fate of many patients and new diagnostic strategies with the potential of changing clinical practice. In this article, several experts discuss what lies ahead.

Automated summary

In the past 20 years, cancer research has entered a new era, shifting its focus from cancer cells themselves to the complex interactions within the tumor and with the host, which ultimately determine the evolution and progression of the disease. The development of immunotherapies and new diagnostic strategies has changed the fate of many patients and has the potential to revolutionize clinical practice.